13F

Stock

Vivos Therapeutics, Inc.

VVOS · held by 25 managers

Reported value

$2.15M

Holders

Holders’ est. mark

Need a prior quarter

Largest holder

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange

Who left

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.